FDA approval of zuranolone - Zurzuvae

directory of Chem Help ASAP videos: www.chemhelpasap.com/youtube/
channel email: [e-mail]
This video describes the approval of zuranolone (Zurzuvae), a GABA-A positive allosteric modulator for the treatment of postpartum depression. Zuranolone was approved by the U.S. FDA on August 4, 2023. The sponsor of the NDA was Sage Therapeutics and Biogen. The structural features, ADME/PK, and key safety risks of zuranolone are discussed.
This video was created for academic purposes. The creator of the video has no financial stake in Sage Therapeutics and Biogen or relationship with the FDA.